Emivirine
Jump to navigation
Jump to search
Names | |
---|---|
Preferred IUPAC name
6-Benzyl-1-(ethoxymethyl)-5-(propan-2-yl)pyrimidine-2,4(1H,3H)-dione | |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C17H22N2O3 | |
Molar mass | 302.36818 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Emivirine (MKC-442) is a failed experimental agent for the treatment of HIV. It is a non-nucleoside reverse transcriptase inhibitor.[1] While emivirine showed promising antiviral activity in vitro, it failed to show sufficient efficacy in human trials. However it is still notable as an early proof of concept, which led to the discovery of a number of related antiviral drugs.[2]
References
- ^ "Emivirine".
- ^ Calenbergh SV, Herdewijn P. A heterogeneous collection of novel antiviral pyrimidines. Expert Opinion on Therapeutic Patents 2000; 10(3):289-295. DOI:10.1517/13543776.10.3.289
Categories:
- Articles without KEGG source
- Articles with changed EBI identifier
- Articles with changed ChemSpider identifier
- Articles with changed FDA identifier
- Articles with changed InChI identifier
- Articles containing unverified chemical infoboxes
- Chembox image size set
- Articles with short description
- Short description matches Wikidata
- Abandoned drugs
- Non-nucleoside reverse transcriptase inhibitors
- Pyrimidinediones
- Isopropyl compounds
- Benzyl compounds
- All stub articles
- Antiinfective agent stubs